Intraokulare Entzündung nach IVOM
-
Published:2019
Issue:1
Volume:5
Page:24-25
-
ISSN:2297-0118
-
Container-title:Karger Kompass Ophthalmologie
-
language:en
-
Short-container-title:Karger Kompass Ophthalmol
Reference12 articles.
1. Daien V, Nguyen V, Essex RW, et al.: Incidence and outcomes of infectious and noninfectious endophthalmitis after intravitreal injections for age-related macular degeneration. Ophthalmology 2018;125:66-74.
2. Lommatzsch AP, Bartels S, Heimes B, et al.: Endophthalmitis als schwere Komplikation der intravitrealen Medikamentengabe. Klin Monatsbl Augenheilkd 2013;230:1130-1134.
3. Mehta H, Tufail A, Daien V, et al.: Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors. Prog Retin Eye Res 2018;65:127-146.
4. Grzybowski A, Told R, Sacu S, et al.: 2018 update on intravitreal injections: euretina expert consensus recommendations. Int J Ophthalmol 2018;239:181-193.
5. Trivizki O, Schwartz S, Negri N, et al.: Noninfectious inflammatory response following intravitreal bevacizumab injections: description of a cluster of cases in two centers and a review of the literature. Ophthalmologica 2018;240:163-166.